- Home
- NEO vs TRIN Comparison
NEO vs TRIN Comparison
Compare NEO & TRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- TRIN
- Stock Information
- Founded
- NEO 2001
- TRIN 2007
- Country
- NEO United States
- TRIN United States
- Employees
- NEO N/A
- TRIN N/A
- Industry
- NEO Precision Instruments
- TRIN Finance/Investors Services
- Sector
- NEO Health Care
- TRIN Finance
- Exchange
- NEO Nasdaq
- TRIN Nasdaq
- Market Cap
- NEO 1.2B
- TRIN 1.2B
- IPO Year
- NEO 1999
- TRIN 2021
- Fundamental
- Price
- NEO $10.21
- TRIN $15.11
- Analyst Decision
- NEO Buy
- TRIN Buy
- Analyst Count
- NEO 10
- TRIN 4
- Target Price
- NEO $12.56
- TRIN $15.63
- AVG Volume (30 Days)
- NEO 5.6M
- TRIN 783.8K
- Earning Date
- NEO 10-28-2025
- TRIN 11-05-2025
- Dividend Yield
- NEO N/A
- TRIN 13.55%
- EPS Growth
- NEO N/A
- TRIN 32.58
- EPS
- NEO N/A
- TRIN 2.25
- Revenue
- NEO $709,162,000.00
- TRIN $254,887,000.00
- Revenue This Year
- NEO $10.40
- TRIN $27.19
- Revenue Next Year
- NEO $10.11
- TRIN $8.97
- P/E Ratio
- NEO N/A
- TRIN $6.70
- Revenue Growth
- NEO 10.10
- TRIN 33.44
- 52 Week Low
- NEO $4.72
- TRIN $12.50
- 52 Week High
- NEO $19.12
- TRIN $16.82
- Technical
- Relative Strength Index (RSI)
- NEO 60.50
- TRIN 48.93
- Support Level
- NEO $9.83
- TRIN $15.03
- Resistance Level
- NEO $11.41
- TRIN $15.38
- Average True Range (ATR)
- NEO 0.48
- TRIN 0.26
- MACD
- NEO -0.05
- TRIN 0.07
- Stochastic Oscillator
- NEO 48.03
- TRIN 69.32
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About TRIN Trinity Capital Inc.
Trinity Capital Inc is a closed-end, non-diversified management investment company. The company is engaged in providing debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Its equipment financings involve loans for general or specific use, including acquiring equipment, secured by the equipment or other assets of the portfolio company.